Int J Biol Macromol 101:502517 Tashakori-Miyanroudi M, Souresrafil A, Hashemi P, Ehsanzadeh SJ, Farrahizadeh M, Behroozi Z (2021) Prevalence of depression, anxiety, and psychological distress in patients with epilepsy during COVID-19: a systematic review
Semaglutide dry mouth profile Semaglutide, marketed as Ozempic and Wegovy, carries a reporting-odds ratio of 1.34 for dry mouth in adverse event databases
Do that one swap for a full week until it's automatic
Imagine feeling more energized, focused, and ready to take on the day without that sluggish afternoon slump
The drug delivers a mean weight loss of around 15% with consistent tolerability, supporting long-term adherence and prescriber confidence
Patients frequently report clearer skin, fewer brain-fog days, and generally more predictable energy